| 1 |
29122850 | Differential preventive activity of sulindac and atorvastatin in Apc+/Min-FCCCmice with or without colorectal adenomas. | 2018 Jul |
1 |
| 2 |
29434827 | Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer. | 2018 Jan |
2 |
| 3 |
23996931 | Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention. | 2014 Jan |
2 |
| 4 |
19784846 | Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer. | 2010 Apr |
2 |
| 5 |
19755659 | Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations. | 2009 Nov |
2 |
| 6 |
16950562 | Defective acute apoptotic response to genotoxic carcinogen in small intestine of APC(Min/+) mice is restored by sulindac. | 2007 Apr 18 |
1 |
| 7 |
15688007 | Methylation in the p21WAF1/cip1 promoter of Apc+/-, p21+/- mice and lack of response to sulindac. | 2005 Mar 17 |
1 |
| 8 |
12584176 | Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. | 2003 Feb |
4 |
| 9 |
12663524 | Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. | 2003 Mar |
1 |
| 10 |
9927046 | Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. | 1999 Jan 15 |
1 |
| 11 |
10582710 | Correspondence re: N.N. Mahmoud et al., Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac. Cancer Res., 59: 353-359, 1999. | 1999 Nov 15 |
1 |